SCHEMBL4855800

SCHEMBL4855800

COc1ccc2[nH]c(C(C)Oc3ccc(/C=C4/SC(=O)NC4=O)cc3)cc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 6/20 0.57
PIM2 Q9P1W9 5/20 0.57
AKR1B1 P15121 2/20 0.57
NPC1 O15118 1/20 0.57
RAB9A P51151 1/20 0.57
GSK3B P49841 4/20 0.49
HPGD P15428 2/20 0.48
CSNK2A1 P68400 2/20 0.47
DYRK1A Q13627 2/20 0.47
PIM3 Q86V86 2/20 0.47
POLB P06746 1/20 0.47
CSNK2A2 P19784 1/20 0.47
CLK1 P49759 1/20 0.47
CSNK2B P67870 1/20 0.47
DYRK1B Q9Y463 1/20 0.47
PDE4B Q07343 1/20 0.47
HDAC4 P56524 2/20 0.46
HDAC8 Q9BY41 1/20 0.45
CDC7 O00311 1/20 0.45
DAPK3 O43293 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1248947 0.78 PIM1 (0.78) PIM1PIM2AKR1B1NPC1RAB9A
SCHEMBL1248944 0.78 PIM1 (0.78) PIM1PIM2AKR1B1NPC1RAB9A
SCHEMBL1248930 0.78 GSK3B (0.64) PIM1PIM2AKR1B1NPC1RAB9A
SCHEMBL1248928 0.78 GSK3B (0.64) PIM1PIM2AKR1B1NPC1RAB9A
SCHEMBL4855804 0.76 PIM1 (0.57) PIM1PIM2AKR1B1NPC1RAB9A
SCHEMBL1247705 0.75 PIM1 (1.00) PIM1PIM2AKR1B1NPC1RAB9A
SCHEMBL2546911 0.75 PIM1 (1.00) PIM1PIM2AKR1B1NPC1RAB9A
SCHEMBL1247708 0.75 PIM1 (1.00) PIM1PIM2AKR1B1NPC1RAB9A
SCHEMBL2546776 0.74 PIM1 (0.69) PIM1PIM2AKR1B1NPC1RAB9A
SCHEMBL4857392 0.73 PPARG (0.52) HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050159463-A1 Indole derivatives NEURIM PHARMACEUTICALS (1991) LTD. (IL) 2005-07-21 US claimed
EP-1189583-B1 INDOLE DERIVATIVES NEURIM PHARMA 1991 (IL) 2005-07-20 EP claimed
EP-1189583-A4 INDOLE DERIVATIVES NEURIM PHARMA 1991 (IL) 2004-04-14 EP claimed
EP-1189583-A1 INDOLE DERIVATIVES NEURIM PHARMACEUTICALS (1991) LIMITED (IL) 2002-03-27 EP claimed
WO-2000072815-A1 INDOLE DERIVATIVES NEURIM PHARMACEUTICALS (1991) LTD. (IL) 2000-12-07 WO claimed
US-7355054-B2 Indole derivatives NEURIM PHARMACEUTICALS (1991) LTD. (IL) 2008-04-08 US disclosed
US-20050159463-A1 Indole derivatives NEURIM PHARMACEUTICALS (1991) LTD. (IL) 2005-07-21 US disclosed
EP-1189583-B1 INDOLE DERIVATIVES NEURIM PHARMA 1991 (IL) 2005-07-20 EP disclosed
US-6858642-B1 Indole derivatives NEURIM PHARMACEUTICALS (1991) LTD. (IL) 2005-02-22 US disclosed
EP-1189583-A4 INDOLE DERIVATIVES NEURIM PHARMA 1991 (IL) 2004-04-14 EP disclosed
EP-1189583-A1 INDOLE DERIVATIVES NEURIM PHARMACEUTICALS (1991) LIMITED (IL) 2002-03-27 EP disclosed
WO-2000072815-A1 INDOLE DERIVATIVES NEURIM PHARMACEUTICALS (1991) LTD. (IL) 2000-12-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050159463-A1 Indole derivatives IDO1, IDO2, H1-0 PIM1 3614/4885PIM2 3451/4885AKR1B1 228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.